Stanley Laman Group, Ltd. Cerus Corp Transaction History

Stanley Laman Group, Ltd.

  • $648 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022
SELL
$4.41 - $5.69 $99,075 - $127,831
-22,466 Reduced 5.64%
375,796 $1.99 Million
Q1 2022

Apr 21, 2022
BUY
$4.81 - $6.99 $347,541 - $505,055
72,254 Added 22.16%
398,262 $2.19 Million
Q4 2021

Jan 25, 2022
BUY
$5.97 - $7.93 $1.95 Million - $2.59 Million
326,008 New
326,008 $2.22 Million

Others Institutions Holding CERS

# of Institutions
156
Shares Held
147M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Stanley Laman Group, Ltd. Portfolio

Follow Stanley Laman Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stanley Laman Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email